S1P3 activator (Angiob)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameS1P3 activator (Angiob)
Drug Alias NameSphingosine-1-phosphate-3 receptor activator (Hebrew University of Jerusalem)S1P3 activator (Hebrew University of Jerusalem)Sphingosine-1-phosphate-3 receptor activator (Angiob)R-002L106R-002L103
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionSphingosine 1-phosphate receptor 3 agonistsAngiogenesis stimulants
TargetsSphingosine 1-phosphate receptor 3
Therapy Area/IndicationsIschemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Hebrew University Of Jerusalem
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAngiob LtdThe Hebrew University Of Jerusalem
Active IndicationsN/A
Inactive IndicationsIschemia

Other Information

ATC CodeN/A
Related LinksN/A